update: Avastin decision postponed

The heat is on. It looks like the FDA is receiving heavy lobbying on both sides, so it has postponed, until mid-December, its decision on revoking the approval for Avastin® as treatment for breast cancer. Briefly, if the FDA revokes its  approval for Avastin as a breast-cancer treatment, Avastin would remain only as an off-label treatment (it remains an approved treatment for brain, colon, kidney and lung cancers) and thus may not receive support from insurance carriers.
F.D.A. Postpones Rule on Breast Cancer Drug. By Andrew Pollack, The New York Times 9-17-10

5 6 7 8
© 2004-2010 Donna Peach. All rights reserved.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s